Is there any difference in the quality score format of a sample (FASTQ) file generated by HiSeq 2000 and that by Genome Analyzer II ?
Thank you,
Vedbar
Thank you,
Vedbar
-
-
There are no differences between machines, but there are between software versions. The recently released CASAVA 1.8 outputs FASTQ files with Q-scores using Phred+33 encoding as opposed to the Phred+64 used in previous versions. -
Thank you for your answer.Comment
-
Hi kmcarr,
I know that CASAVA v1.8 is reported to produce Phred+33 Q-scores, but I just checked the export files from our last run and observed quality values up to 'i' (which would be 72!). I'll contact Illumina tech support later today and get the scoop.
HaroldComment
-
Follow-up:
The bam files contain Phred+33 Q-scores, while the export files contain Phred+64.
Aaaarrgghh!Comment
-
See new post on the earlier thread, http://seqanswers.com/forums/showpos...9&postcount=64Originally posted by HESmith View Post
It sounds like they've fixed their FASTQ (good), but not the in house "export" format (confusing!)
SAM/BAM have always explicitly required PHRED scores + 33 for the ASCI encoding (like Sanger FASTQ).
Probably best to continue this here: http://seqanswers.com/forums/showthread.php?t=8895Comment
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification,...10-30-2026, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment